ClinicalTrials.govpublic full text
Evaluation of Skin Health and QoL in Pts Receiving Anti-PD1/PDL1/CTLA4 or CDK Inhibitors.
lung cancer, breast cancer, kidney cancer, bladder cancer, gastric cancer, skin cancer
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 253008
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.